chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea,  Dizziness,  Tinnitus,  brain fog All still ongoing
6/10/03 Pt in to clinic with what appears to mild case of varicella. Mother states she and child went to Mexico 2 weeks ago and child had contact with cousin who had an active case of varicella. Child started with fever and chicken pox areas yesterday.
Patient said that her arm has been hurting ever since she received vaccine and that is not getting better. Patient felt like it was administered high on the arm.
3 patients received PROQUAD and 1 patient received VARIVAX vaccine which experienced a temp excursion; No additional AE details reported; This spontaneous report was received from an officer manager referring to four patients of unknown age and gender. The patients' concurrent conditions, medical history, and concomitant medications were not reported.   On an unknown date, 3 patients were vaccinated with measles, mumps, rubella, and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # T034823 with an expiration date on 11-APR-2022), and 1 patient was vaccinated with included varicella virus vaccine live (oka/merck)(VARIVAX) (lot# 1010311 with an expiration date on 24-MAR-2022). Both vaccines were exposed to a temperature excursion of 25.6°F degrees Fahrenheit (°F) for 3 hours before administration (product storage error). The data logger was not involved.  Strength, dose, anatomical location, and route of administration were not reported for all vaccines.     No additional adverse events were reported.  There was no previous temperature excursion reported.  Lot Number 1010311 was not valid for varicella virus vaccine live (oka/merck)(VARIVAX).
Platelets count has been dropping since receiving the vaccine/low platelets; This case was reported by a pharmacist via call center representative and described the occurrence of platelets decreased in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number ZM3D2, expiry date 3rd April 2022) for prophylaxis.   On 26th February 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 26th February 2020, immediately after receiving Shingrix, the patient experienced platelets decreased. On an unknown date, the outcome of the platelets decreased was not recovered/not resolved.   It was unknown if the reporter considered the platelets decreased to be related to Shingrix.  Additional case details were reported as follows: The patient's platelets count has been dropping since she received Shingrix.  Her normal platelet count was 220 which has dropped to 30 and then 20 in the last few weeks. The reporter consented to follow up. This case has been linked with US2020050262 and US2020050264, reported by same reporter.
Experienced pain at the left deltoid injection site while vaccine was administered, then severe L shoulder pain later in the day that severely limited mobility of the LUE for ~1 week. The pain & difficulty with UE mobility gradually decreased over time, then resolved.
2 booster doses administered past 12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 booster doses administered past 12 hours post puncture) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (2 booster doses administered past 12 hours post puncture). On 25-Jan-2022, EXPIRED PRODUCT ADMINISTERED (2 booster doses administered past 12 hours post puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided. 1st booster was administered 25Jan2022 at 10:35 AM and the 2nd booster was administered 25-Jan-2022 at 11:45 AM. Date the vial was initially stored in the refrigerator: 18-Jan-2022 at 7:05 AM. Date and time vial was first punctured: 24-Jan-2022 at 9:20AM. Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F): 24-Jan-2022 9:20 AM until 10:35 AM 25-Jan-2022 and until 2nd administration at 11:45 AM 25-Jan-2022.
Pt C/O L arm hurting for 1 week and developing a "bump" under the skin at the site of injection for 1 month. Following the injection had difficulty raising her arm above shoulder height for several days. Pt didn't notify clinic. Shared information upon return for second GARDASIL 9 vaccine.
Patient's daughter came in at drop off asking for first dose of Moderna for her dad, she told our technician that she made appointment online for Moderna vaccine and answered questions for her Dad already. And our technician asked the daughter that is it the first dose of Covid vaccine and daughter said yes. Then we processed, gave patient vaccines and appointment card for the next dosage while the daughter went shopping. When patient was waiting for 15 minutes and pharmacist gave him his CDC card for first dosage of Moderna, patient told pharmacist that this is the second dose not the first dose, then we asked and he said he got Covid vaccines Pfizer begin of 2021 and he did not get the second dose because they had to wait for 4 hours and his daughter didn't like it so they left . Then when daughter came back to pick him up today, our pharmacists and technician went out to verify which her. And she told her dad that " why you told them that?". And she admitted that she didn't told us earlier , she just wanted her Dad to get another vaccine and she told rudely to our both pharmacists that " It doesnt matter which Covid vaccines, I don't care" . Then the daughter asked about second dose of Moderna Covid vaccine, so we told patient that 3rd dose of Covid vaccine is not approved yet, pay attention to her Dad next couple days for any reactions. We watched patient for over 30 minutes and no reaction.
Arm pain after the shot. Last and worsen over a day. Very painful now. ~24hr after the shot Flu like symptoms: muscle pain all over the body, headache, skin very sensitive/irritable. Whole body is weak. Mild lower abdominal pain. Affected normal life by a large degree.
The pain travels throughout the body/the pain is still with me; Wants to speak a specialist about the Moderna covid19 vaccine that he received, and his medical status after the shots.3 days after 2nd dose i been having severe headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (The pain travels throughout the body/the pain is still with me), VACCINATION COMPLICATION (Wants to speak a specialist about the Moderna covid19 vaccine that he received, and his medical status after the shots.) and HEADACHE (3 days after 2nd dose i been having severe headaches) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (The pain travels throughout the body/the pain is still with me), VACCINATION COMPLICATION (Wants to speak a specialist about the Moderna covid19 vaccine that he received, and his medical status after the shots.) and HEADACHE (3 days after 2nd dose i been having severe headaches). At the time of the report, PAIN (The pain travels throughout the body/the pain is still with me) had not resolved and VACCINATION COMPLICATION (Wants to speak a specialist about the Moderna covid19 vaccine that he received, and his medical status after the shots.) and HEADACHE (3 days after 2nd dose i been having severe headaches) outcome was unknown.            No concomitant product was provided by the reporter. No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Nov-2021: Significant Follow Up Appended; Reporter's Email; Patient age added; Events Added;
After the vaccine she noted petechiae about 1 week post booster shot. She experienced: fever and flu-like symptoms, unable to move her arm, and mucositis and bleeding when brushing her teeth. Then, the 56 year old female presents to the ED ~2 weeks after the moderna vaccine booster with fatigue, trouble swallowing, and hemoptysis. Patient woke up fatigued and then later felt something in her throat, and it was noted to be bright red blood. Went to the urgent care clinic and was told to go to the ED. Patient in the hospital had petechiae on her left arm, and lower extremeties. Platelet counts revealed thrombocytopenia. After ruling out other likely causes, patient was found to have acute ITP secondary to the Moderna booster shot. Patient was treated with dexamethasone loading dose 40mg IVPB for 4 doses, and IV Immune Globulin 90 grams for 2 doses. Patient responded well, and is now following up as an outpatient with the hematology service.
Received a vaccine which was more than 30 days in the refrigerator; Received a vaccine which was more than 30 days in the refrigerator; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a vaccine which was more than 30 days in the refrigerator) and PRODUCT STORAGE ERROR (Received a vaccine which was more than 30 days in the refrigerator) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a vaccine which was more than 30 days in the refrigerator) and PRODUCT STORAGE ERROR (Received a vaccine which was more than 30 days in the refrigerator). On 07-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Received a vaccine which was more than 30 days in the refrigerator) and PRODUCT STORAGE ERROR (Received a vaccine which was more than 30 days in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Pain in arm both times.; After second dose, severe cough developed 2 days after.; This is a spontaneous report from a contactable consumer or other non hcp, the patient reported that:  A 32-years-old male patient received bnt162b2 (BNT162B2 Formulation: Solution for injection, Batch/Lot Number: SW0151), dose 2, administered in Arm Left on 14Apr2021 17:15 as dose 2, single for covid-19 immunisation. Historical vaccine, the patient took first dose bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EN6207), dose 1 administered in Arm Left on 17Mar2021 12:00 as dose 1, single for covid-19 immunisation. Medical history included bicuspid aortic valve from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. After the second dose, on 15Apr2021 20:15 patient experienced pain in arm both times and severe cough developed two days after. No treatment received. No other vaccine in four weeks. Patient did not have covid prior to vaccination. He was not tested for covid post vaccination. No known allergies were reported. The outcome of the events was not recovered.  Follow-up (18Aug2021): Follow-up attempts are completed. No further information is expected.
Loss of balance; Vomiting; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), BALANCE DISORDER (Loss of balance) and VOMITING (Vomiting) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Dizziness). On 31-Mar-2021, the patient experienced BALANCE DISORDER (Loss of balance) and VOMITING (Vomiting). The patient was treated with MECLOZINE HYDROCHLORIDE (BONINE) at an unspecified dose and frequency. On 29-Mar-2021, DIZZINESS (Dizziness) had resolved. At the time of the report, BALANCE DISORDER (Loss of balance) and VOMITING (Vomiting) outcome was unknown.            No relevant concomitant medications were reported.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.
Left shoulder (Upper Arm) reddish, feverish, firm, slight itch, slight pain.  This has been going on since the 2nd day after injection and this is 5th day after injection.  Applied cortisone cream (OTC)
tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 071F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired). At the time of the report, FATIGUE (tired) outcome was unknown.            No concomitant medications were reported No treatment drugs were reported
THE PATIENT TOLD HER MOTHER SHE FELT FAINT.  SHE THEN FAINTED BUT NEVER LOST CONSCIOUSNESS.  SHE BEGAN TO HYPERVENTILATE AND COMPLAINED OF TINGLING IN HER HANDS AND FEET.  SHE THEN COMPLAINED OF DYSTONIA IN HER HANDS.  THE EMS TOOK HER TO THEIR VAN.
1st dose to L deltoid around 0725. I went at sat down to wait my 15 minutes and approximately 5-10 mins later I immediately began feeling completely flushed, red hot followed by chest tightness and throat tightness.  Upon standing up I felt very dizzy and had a strange sense of 'impending doom'. The RN recording my Vital signs had me take a picture of them to trend and send to the ED which is where I was later sent (see VS below) 0733- bp 171/92, hr 83, sp02 100% "hot flushed, chest tightness" 0735- BP 159/97, HR 91, SP02 99% 0740- BP 170/95, HR 76, SP02 100%, "chest tightness better, no itching, or rash"   0745- BP 155/90, HR 76, SP02 100% 0750- BP 161/94, HR 88, SP02 100% "anxiety,/throat tightness, feeling super hot"- here I again had another episode that felt like total body flushing, and began taking my layers of jackets and scrub cap off feeling diaphoretic. (My normal BP is 120/70's and HR 60's)  Upon standing to get to the w/c to be taken to the ER I remember my legs felt tingly and liquidy like jello and that my balance felt off. I got to the Emergency Room a little before 0825 an hour post vaccine. My chest and throat tightness had improved slightly and the flushing reaction had seemed to stop as I now recall feeling very chilled asking for several blankets. I was monitored in the ER for about 1.5hrs thankfully not requiring any epinephrine.
Starting about 2 weeks after my booster shot I woke up experiencing an itchy rash all over my torso and scalp. I started taking Zyrtec the next day and that alleviated the rash. I'm still experiencing the rash if I don't take a daily dose of Zyrtec, and it shows up on different parts of my body at different times (mostly my torso, especially upper back, belly, and chest). I know that a rash can be a common side effect to the booster shot but I figured I'd better report this since it's been going on for a month.
Throat became itchy and scratchy.  My neck (throat area) was also itchy.
PALPITATIONS (HS OF A FIB), POSITIVE COVID TEST, ACUTE RESPIRATORY FAILURE
He got his vaccine, and first his body hurt everywhere.  It was very painful and felt like everything in his body was hurting, aching.  He felt nauseated, had a bit of fever 100 degrees, and normally his temp is 97.5  He was miserable.  He couldn't do anything as he hurt so bad.  He felt that it would go away and waited 2 days and it didn't go away and was not able to get up to get anything to eat or drink.  called the neighbors who called 9-1-1 and the EMT's and took his VS and took a blood sample for his diabetes and said that his VS were normal and asked if he wanted to go to the hospital, and they did not see anything wrong with him and he declined and they left.  He thought that he would feel better, and started to, not nauseated.  He was also very dizzy and really could not walk.  His neighbor brought him a walker so he could get around otherwise he would fall down into a chair.  Finally after a couple of weeks felt like he would be able to stand up without falling down.  Now every time that he stands up he gets light headed, and is able to get around without any problems, and take care of himself, but has to be real careful with the vertigo that will not go away completely.  It's been 7 weeks and it's not completely gone and wonders if it's going to go away.   He has noticed that the more he gets up that it does improve.
Lower grade fever, chills, muscle aches, headache, fatigue. All symptoms were from around 3:00 pm 09/13/2010 til 12:00 pm 09/14/10.  Headache (varied intensity) lasted until late afternoon of 09/15/10.
Hiatal hernia; Doesn't have the ability to swallow; A spontaneous report was received from a consumer concerning a 87-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  that doesn't have the ability to swallow (dysphagia) and hiatal hernia.  . The patient's medical history was not provided. Concomitant medications was not  reported.  On an undisclosed date, approximately three weeks prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Lot number: unknown)  for prophylaxis of COVID-19 infection.  On an undisclosed date approximately three weeks after receiving mRNA-1273, the patient did not have the ability to swallow. Her doctors blamed hiatal hernia. The patient was hospitalized.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable because the patient received her second dose.  The outcome of events was unknown.; Reporter's Comments: The events were consistent with anatomical anomaly of gastrointestinal tract. Company assessed the events to be unlikely related to company product.
Information has been received from a nurse practitioner concerning an "approximately four months old" female who "approximately two months ago", in approximately December 2010, was vaccinated with a dose of ROTATEQ (therapy route and lot # not provided). Secondary suspect therapy included a dose of RECOMBIVAX (therapy route and lot # not provided). Patient was also given PENTACEL and PREVNAR. It was reported that "approximately two months ago", in approximately December 2010, the patient was given ROTATEQ at another Health Care Professional (HCP)'s office, and threw it up and so the other HCP's office gave the patient a second dose of ROTATEQ and the patient had a seizure. Treatment given for the adverse event (AE) was unspecified. Patient sought unspecified medical attention. AE improved while patient was on therapy. Therapy continued and was reported as not reappear after reintroduction. At the time of reporting, the patient had recovered. Upon internal review, seizure was determined to be an other important medical event. Follow-up information was received from a licensed practical nurse who reported that the patient was a 45 day old female with no known drug allergies. On 18-NOV-2011 patient threw up the first dose of ROTATEQ and right after it the patient was given another dose. Either dose was with lot # 667459/0502Z. One to two days after that dosing, on approximately 19-NOV-2011 the patient had the seizure, event learned from the family at the time of patient's first visit on 04-FEB-2011. On 01-MAR-2011, patient received the second dose of ROTATEQ (therapy route and lot # not provided) with no problem. No further information is available.
covid + between doses; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid + between doses) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN C [ASCORBIC ACID] and TOCOPHEROL (VITAMIN E [TOCOPHEROL]) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced COVID-19 (covid + between doses). At the time of the report, COVID-19 (covid + between doses) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, SARS-CoV-2 test: negative (Negative) Negative. On 08-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
8/4 - Fever 102-103 degrees. Hospital: 8/5 - Fever 103 degrees. Bulging Fontanelle, given ROCEPHIN. 8/6 - Fever 101-102  on TYLENOL, swollen fontanelle. 8/7 - Fever 100 degrees, fontanelle still raised, white. 8/8 - Fever 99 degrees off TYLENOL.
Sore arm last 3-4 days. Chills that lasted 7 hours
patient was administered dose while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the patient was administered dose while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patient was administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the patient was administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patient was administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the patient was administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patient was administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the patient was administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.